Opening the door on entry inhibitors in HIV: Redefining the use of entry inhibitors in heavily treatment experienced and treatment‐limited individuals living with HIV

INTRODUCTION: Entry inhibitors are a relatively new class of antiretroviral therapy and are typically indicated in heavily treatment experienced individuals living with HIV. Despite this, there is no formal definition of ‘heavily treatment experienced’. Interpretation of this term generally includes...

Descripción completa

Detalles Bibliográficos
Autores principales: Orkin, Chloe, Cahn, Pedro, Castagna, Antonella, Emu, Brinda, Harrigan, P Richard, Kuritzkes, Daniel R., Nelson, Mark, Schapiro, Jonathan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546304/
https://www.ncbi.nlm.nih.gov/pubmed/35293094
http://dx.doi.org/10.1111/hiv.13288

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9546304/
https://www.ncbi.nlm.nih.gov/pubmed/35293094
http://dx.doi.org/10.1111/hiv.13288

Ejemplares similares